J. Jac

发表

Vaccination of Prostate Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax): A Phase 2 Trial

R. Amato, S. Saxena, S. Naylor, 2008, Journal of immunotherapy.

A phase I study with a daily regimen of the oral mTOR inhibitor RAD001 (Everolimus) plus sorafenib for patients with metastatic renal cell cancer (MRCC)

R. Amato, S. Chiang, J. Willis, 2008 .

Abstract A100: A phase 1, first in human, study of SCH 900105, an antihepatocyte growth factor (HGF) monoclonal antibody, in subjects with advanced solid tumors

M. Cotreau, A. Tolcher, G. Weiss, 2009 .

Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results.

R. Amato, J. Hernandez-McClain, J. Jac, 2008, Clinical genitourinary cancer.

A phase II trial of intra-patient dose escalated-sorafenib in patients (pts) with metastatic renal cell cancer (MRCC)

S. Srinivas, R. Amato, R. Hauke, 2007 .

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

R. Amato, J. Willis, S. Saxena, 2009, Cancer.

Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC

J. Ahn, M. Ahn, Keunchil Park, 2018, Clinical pharmacology in drug development.

The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT)

S Richardson, S. Richardson, S. Chiang, 2007, Biomedical imaging and intervention journal.

Vaccination of Renal Cell Cancer Patients with Modified Vaccinia Ankara Delivering Tumor Antigen 5T4 (TroVax) Administered with Interleukin 2: A Phase II Trial

R. Amato, J. Willis, S. Saxena, 2008, Clinical Cancer Research.

Interferon-&agr; in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial

R. Amato, J. Hernandez-McClain, J. Jac, 2008, Anti-cancer drugs.

Targeted Anti-Cancer Therapies for Renal Cancer

R. Amato, J. Jac, 2012, Drugs.

Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma

C. Hofmeister, M. Cotreau, A. Tolcher, 2014, British Journal of Cancer.

Pilot study of rapamycin in patients with hormone-refractory prostate cancer.

R. Amato, S. Saxena, Robert J Amato, 2008, Clinical genitourinary cancer.

Randomized phase II study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.

M. Cotreau, T. Mok, E. Tan, 2011, Journal of Clinical Oncology.

Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.

M. Cotreau, M. Ahn, E. Tan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-α (IFN-α): A Phase 2 Trial

R. Amato, J. Willis, S. Saxena, 2009, Journal of immunotherapy.

Phase I study of SCH 900105 (SC), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb), as a single agent and in combination with erlotinib (E) in patients (pts) with advanced solid tumors.

M. Cotreau, A. Tolcher, G. Weiss, 2010 .

A phase II study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic renal cell carcinoma which has progressed on tyrosine kinase inhibition therapy

R. Amato, J. Willis, S. Saxena, 2008 .

Vaccination of renal cell cancer (RCC) patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax [T]) administered + low dose interleukin-2 (IL-2): A phase II trial

R. Amato, J. Willis, S. Saxena, 2008 .

The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT).

R. Amato, B. Teh, S. Chiang, 2007 .

Biij Biomedical Imaging and Intervention Journal the Treatment of Primary and Metastatic Renal Cell Carcinoma (rcc) with Image-guided Stereotactic Body Radiation Therapy (sbrt)

S. Richardson, S. Chiang, C. Bloch, 2022 .

Vaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-α (IFN-α): A Phase 2 Trial

R. Amato, J. Willis, S. Saxena, 2009, Journal of immunotherapy.

A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC).

R. Amato, S. Chiang, J. Willis, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.